Impact of repeated nicotine and alcohol coexposure on in vitro and in vivo chlorpyrifos dosimetry and cholinesterase inhibition

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 74, Issue 20, 2011, Pages 1334-1350

  Lee, S ^a   Poet, T S ^b   Smith, J N ^b   Hjerpe, A L ^b   Gunawan, R ^b   Timchalk, C ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHLORPYRIFOS; CHOLINESTERASE; CYTOCHROME P450; NICOTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; INTOXICATION; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; URINALYSIS; XENOBIOTIC METABOLISM;

ALCOHOLS; ANIMALS; BRAIN; CHLORPYRIFOS; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; INSECTICIDES; MALE; MICROSOMES, LIVER; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

NICOTIANA TABACUM; RATTUS;

EID: 80052675179     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2011.567958     Document Type: Article

References (70)

1. Bachtell, R. K., and Ryabinin, A. E. 2001. Interactive effects of nicotine and alcohol co-administration on expression of inducible transcription factors in mouse brain. Neuroscience 103:941-954. (Pubitemid 32289306)
2. Bakke, J. E., Feil, V. J., and Price, C. E. 1976. Rat urinary metabolites from O, O-diethyl-O-(3, 5, 6-trichloro-2-pyridyl) - phosphorothioate. J. Environ. Sci. Health B 11:225-230.
3. Batel, P., Pessione, F., Maitre, C., and Rueff, B. 1995. Relationship between alcohol and tobacco dependencies among alcoholics who smoke. Addiction 90:977-980.
4. Benowitz, N. L. 2009. Pharmacology of nicotine: Addiction, smoking-induced disease, and therapeutics. Annu. Rev. Pharmacol. Toxicol. 49:57-71.
5. Bien, T. H., and Burge, R. 1990. Smoking and drinking: A review of the literature. Int. J. Addict. 25:1429-1454.
6. Blomqvist, O., Ericson, M., Johnson, D. H., Engel, J. A., and Söpalm, B.. 1996. Voluntary ethanol intake in the rat: Effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment. Eur. J. Pharmacol. 314:257-267. (Pubitemid 26382426)
7. Brzak, K. A., Harms, D. W., Bartels, M. J., and Nolan, R. J. 1998. Determination of chlorpyrifos, chlorpyrifos oxon, and 3, 5, 6-trichloro-2- pyridinol in rat and human blood. J. Anal. Toxicol. 22:203-210. (Pubitemid 28240469)
8. Buisson, B., and Bertrand, D. 2001. Chronic exposure to nicotine upregulates the human a 4 × 2 nicotinic acetylcholine receptor function. J. Neurosci. 21:1819.
9. Buratti, F. M., Volpe, M. T., Meneguz, A., Vittozzi, L., and Testai, E. 2003. CYP-specific bioactivation of four organophosphorothioate pesticides by human liver microsomes. Toxicol. Appl. Pharmacol. 186:143-154. (Pubitemid 36287225)
10. Campbell, J. A., Timchalk, C., Kousba, A. A., Wu, H., Valenzuela, B. R., and Hoppe, E. W. 2005. Negative ion chemical ionization mass spectrometry for the analysis of 3, 5, 6-trichloro-2-pyridinol in saliva of rats exposed to chlorpyrifos. Anal. Lett. 38:939-949. (Pubitemid 40600497)
11. Carpenter, D. O., Arcaro, K., and Spink, D. C. 2002. Understanding the human health effects of chemical mixtures. Environ. Health Perspect. 110(suppl. 1):25.
12. Chambers, J. E., and Chambers, H. W. 1989. Oxidative desulfuration of chlorpyrifos, chlorpyrifos-methyl, and leptophos by rat-brain and liver. J. Biochem. Toxicol. 4:201-203.
13. Chatonnet, A., and Lockridge, O. 1989. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem. J. 260:625-634. (Pubitemid 19155655)
14. Chen, J., Kumar, M., Chan, W., Berkowitz, G., and Wetmur, J. G. 2003. Increased influence of genetic variation on PON1 activity in neonates. Environ. Health Perspect. 111:1403-1409. (Pubitemid 37063172)
15. Clegg, D. J., and van Gemert, M. 1999. Expert panel report of human studies on chlorpyrifos and/or other organophosphate exposures. J. Toxicol. Environ. Health B 2:257-279. (Pubitemid 30054872)
16. Cometa, M. F., Buratti, F. M., Fortuna, S., Lorenzini, P., Volpe, M. T., Parisi, L., Testai, E., and Meneguz, A. 2007. Cholinesterase inhibition and alterations of hepatic metabolism by oral acute and repeated chlorpyrifos administration to mice. Toxicology 234:90-102. (Pubitemid 46517827)
17. De Leon, J., Rendon, D. M., Baca-Garcia, E., Aizpuru, F., Gonzalez-Pinto, Anitua, C., and Diaz, F. J. 2007. Association between smoking and alcohol use in the general population: Stable and unstable odds ratios across two years in two different countries. Alcohol Alcohol 42:252-257. (Pubitemid 47072542)
18. Dohrman, D. P., and Reiter, C. K. 2003. Ethanol modulates nicotine-induced upregulation of nAChRs. Brain Res. 975:90-98. (Pubitemid 36588555)
19. Ellman, G. L., Courtney, K. D., Andres, V., and Featherstone, R. M. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:88-95.
20. Faustman, E. M., Silbernagel, S. M., Fenske, R. A., Burbacher, T. M., and Ponce, R. A. 2000. Mechanisms underlying children's susceptibility to environmental toxicants. Environ. Health Perspect. 108:13-21. (Pubitemid 30168692)
21. Feron, V. J., Cassee, F. R., Groten, J. P., van Vliet, P. W., and van Zorge, J. A. 2002. International issues on human health effects of exposure to chemical mixtures. Environ. Health Perspect. 110(suppl. 6):893-899. (Pubitemid 36204280)
22. Feron, V. J., and Groten, J. P. 2002. Toxicological evaluation of chemical mixtures. Food Chem. Toxicol. 40:825-839. (Pubitemid 34450778)
23. Florek, E., Piekoszewski, W., Kulza, M., Szindzikaszwili, T., Gomolka, E., Chuchracki, M., and Sedziak, A. 2008. Interaction between tobacco smoke and alcohol in animal models. Pharmacol. Rep. 60:985-990.
24. Fuhr, U. 2000. Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans. Clin. Pharmacokinet. 38:493-504. (Pubitemid 30394314)
25. Funk, D., Marinelli, P. W., and Le, A. D. 2006. Biological processes underlying co-use of alcohol and nicotine: Neuronal mechanisms, cross-tolerance, and genetic factors. Alcohol Res. Health 29:186.
26. Gelman, A., Bois, F., and Jiang, J. M. 1996. Physiological pharmacokinetic analysis using population modeling and informative prior distributions. J. Am. Stat. Assoc. 91:1400-1412.
27. Guengerich, F. P. 1994. Analysis and characterization of enzymes. In Principles and methods of toxicology, ed. A. W. Hayes, 1259-1303. New York: Raven Press.
28. Howard, L. A., Micu, A. L., Sellers, E. M., and Tyndale, R. F. 2001. Low doses of nicotine and ethanol induce CYP2E1 and chlorzoxazone metabolism in rat liver. J. Pharmacol. Exp. Ther. 299:542-550. (Pubitemid 32979666)
29. Howard, L. A., Sellers, E. M., and Tyndale, R. F. 2002. The role of pharmacogeneticallyvariable cytochrome P450 enzymes in drug abuse and dependence. Pharmacogenomics 3:185-199. (Pubitemid 34223856)
30. Husain, K., Scott, B. R., Reddy, S. K., and Somani, S. M. 2001. Chronic ethanol and nicotine interaction on rat tissue antioxidant defense system. Alcohol 25:89-97. (Pubitemid 34016034)
31. Kousba, A. A., Poet, T. S., and Timchalk, C. 2007. Age-related brain cholinesterase inhibition kinetics following in vitro incubation with chlorpyrifos-oxon and diazinon-oxon. Toxicol. Sci. 95:147-155. (Pubitemid 44942785)
32. Le Houezec, J., Jacob, P., 3rd, and Benowitz, N. L. 1993. A clinical pharmacological study of subcutaneous nicotine. Eur. J. Clin. Pharmacol. 44:225-230. (Pubitemid 23096148)
33. Lee, S., Busby, A. L., Timchalk, C., and Poet, T. S. 2009. Effects of nicotine exposure on in vitro metabolism of chlorpyrifos in male Sprague-Dawley rats. J. Toxicol. Environ. Health A 72:74-82.
34. Lee, S., Poet, T. S., Smith, J. N., Busby-Hjerpe, A. L., and Timchalk, C. 2010. Effect of in vivo nicotine exposure on chlorpyrifos pharmacokinetics and pharmacodynamics in rats. Chem. Biol. Interact. 184:449-457.
35. Li, T. K., Volkow, N. D., Baler, R. D., and Egli, M. 2007. The biological bases of nicotine and alcohol co-addiction. Biol. Psychiat. 61:1-3. (Pubitemid 44873105)
36. Lieber, C. S. 1997. Cytochrome P-4502E1: Its physiological and pathological role. Physiol. Rev. 77:517-544. (Pubitemid 27184347)
37. Littleton, J., Barron, S., Prendergast, M., and Nixon, S. J. 2007. Smoking kills (alcoholics) ! Shouldn't we do something about it? Alcohol Alcoholism 42:167-173. (Pubitemid 47072532)
38. Lu, C. S., Toepel, K., Irish, R., Fenske, R. A., Barr, D. B., and Bravo, R. 2006. Organic diets significantly lower children's dietary exposure to organophosphorus pesticides. Environ. Health Perspect. 114:260-263. (Pubitemid 43193649)
39. Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., Gardiner, P. S., Grady, S. R., Heberlein, U., Leonard, S. S., Levin, E. D., Lukas, R. J., Markou, A., Marks, M. J., McCallum, S. E., Parameswaran, N., Perkins, K. A., Picciotto, M. R., Quik, M., Rose, J. E., Rothenfluh, A., Schafer, W. R., Stolerman, I. P., Tyndale, R. F., Wehner, J. M., and Zirger, J. M. 2007. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl.) 190:269-319. (Pubitemid 46156883)
40. Miksys, S. L., and Tyndale, R. F. 2002. Drugmetabolizing cytochrome P450s in the brain. J. Psychiat. Neurosci. 27:406-415.
41. Morgan, M. K., Sheldon, L. S., Croghan, C. W., Jones, P. A., Robertson, G. L., Chuang, J. C., Wilson, N. K., and Lyu, C. W. 2004. Exposures of preschool children to chlorpyrifos and its degradation product 3, 5, 6-trichloro-2- pyridinol in their everyday environments. J. Expos. Anal. Environ. Epidemiol. 15:297-309.
42. Mutch, E., and Williams, F. M. 2006. Diazinon, chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver. Toxicology 224:22-32.
43. Nolan, R. J., Rick, D. L., Freshour, N. L., and Saunders, J. H. 1984. Chlorpyrifos: Pharmacokinetics in human volunteers. Toxicol. Appl. Pharmacol. 73:8-15. (Pubitemid 14131600)
44. O'Shaughnessy, J. A., and Sultatos, L. G. 1995. Interaction of ethanol and the organophosphorus insecticide parathion. Biochem. Pharmacol. 50:1925-1932. (Pubitemid 26009902)
45. Omura, T., and Sato, R. 1964. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239:2370-2378.
46. Poet, T. S., Wu, H., Kousba, A. A., and Timchalk, C. 2003. In vitro rat hepatic and intestinal metabolism of the organophosphate pesticides chlorpyrifos and diazinon. Toxicol. Sci. 72:193-200. (Pubitemid 36443097)
47. Pohl, R. J., and Fouts, J. R. 1980. A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal. Biochem. 107:150-155. (Pubitemid 11196637)
48. Pope, C. N. 1999. Organophosphorus pesticides: Do they all have the same mechanism of toxicity? J. Toxicol. Environ. Health B 2:161-181. (Pubitemid 30054869)
49. Quandt, S. A., Arcury, T. A., Rao, P., Snively, B. M., Camann, D. E., Doran, A. M., Yau, A. Y., Hoppin, J. A., and Jackson, D. S. 2004. Agricultural and residential pesticides in wipe samples from farmworker family residences in North Carolina and Virginia. Environ. Health Perspect. 112:382-387. (Pubitemid 38351404)
50. Reinke, L. A., and Moyer, M. J. 1985. p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug. Metab. Dispos. 13:548-552. (Pubitemid 16221450)
51. Richardson, R. J. 1995. Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: A critical review of the literature. J. Toxicol. Environ. Health 44:135-165.
52. Rubin, E., and Lieber, C. S. 1968. Hepatic microsomal enzymes in man and rat: Induction and inhibition by ethanol. Science 162:690-691.
53. Sadler, D. W., Girela, E., and Pounder, D. J. 1996. Post mortem markers of chronic alcoholism. Forensic Sci. Int. 82:153-163. (Pubitemid 26394862)
54. Sams, C., Mason, H. J., and Rawbone, R. 2000. Evidence for the activation of organophosphate pesticides by cytochromes P450 3A4 and 2D6 in human liver microsomes. Toxicol. Lett. 116:217-221.
55. Schlorff, E. C., Husain, K., and Somani, S. M. 1999. Dose-and time-dependent effects of ethanol on plasma antioxidant system in rat. Alcohol 17:97-105. (Pubitemid 29096196)
56. Schoedel, K. A., and Tyndale, R. F. 2003. Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: Summary and implications. Biochim. Biophys. Acta 1619:283-290. (Pubitemid 36160606)
57. Smith, J. N., Campbell, J. A., Busby-Hjerpe, A. L., Lee, S., Poet, T. S., Barr, D. B., and Timchalk, C. 2009. Comparative chlorpyrifos pharmacokinetics via multiple routes of exposure and vehicles of administration in the adult rat. Toxicology 261:47-58.
58. Söderpalm, B., Ericson, M., Olausson, P., Blomqvist, O., and Engel, J. A. 2000. Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav. Brain Res. 113:85-96. (Pubitemid 30645546)
59. Sultatos, L. G. 1994. Mammalian toxicology of organophosphorus pesticides. J. Toxicol. Environ. Health 43:271-289. (Pubitemid 24353635)
60. Tabershaw, I. R., and Cooper, W. C. 1966. Sequelae of acute organic phosphate poisoning. J. Occup. Med. 8:5-20.
61. Tang, J., Cao, Y., Rose, R. L., Brimfield, A. A., Dai, D., Goldstein, J. A., and Hodgson, E. 2001. Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes. Drug Metab. Dispos. 29:1201-1204. (Pubitemid 32800231)
62. Timchalk, C., Busby, A., Campbell, J. A., Needham, L. L., and Barr, D. B. 2007. Comparative pharmacokinetics of the organophosphorus insecticide chlorpyrifos and its major metabolites diethylphosphate, diethylthiophosphate and 3, 5, 6-trichloro-2-pyridinol in the rat. Toxicology 237:145-157. (Pubitemid 47031413)
63. Timchalk, C., Kousba, A., and Poet, T. S. 2002a. Monte Carlo analysis of the human chlorpyrifos-oxonase (PON1) polymorphism using a physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model. Toxicol. Lett. 135:51-59. (Pubitemid 35276537)
64. Timchalk, C., Nolan, R. J., Mendrala, A. L., Dittenber, D. A., Brzak, K. A., and Mattsson, J. L. 2002b. A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans. Toxicol. Sci. 66:34-53. (Pubitemid 34202027)
65. Timchalk, C., and Poet, T. S. 2008. Development of a physiologically basedpharmacokinetic and pharmacodynamic model to determine dosimetry and cholinesterase inhibition for a binary mixture of chlorpyrifos and diazinon in the rat. Neurotoxicology 29:428-443.
66. Trauth, J. A., Seidler, F. J., and Slotkin, T. A. 2000. Persistent and delayed behavioral changes after nicotine treatment in adolescent rats. Brain Res. 880:167-172.
67. Tricker, A. R. 2003. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. Toxicology 183:151-173. (Pubitemid 36005395)
68. Tsutsumi, M., Lasker, J. M., Takahashi, T., and Lieber, C. S. 1993. In vivo induction of hepatic p4502e1 by ethanol: Role of increased enzyme synthesis. Arch. Biochem. Biophys. 304:209-218. (Pubitemid 23214173)
69. Yue, J., Miksys, S., Hoffmann, E., and Tyndale, R. F. 2008. Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: An investigation of induction and time course. J. Psychiat. Neurosci. 33:54-63. (Pubitemid 351252497)
70. Yue, J., Khokhar, J., Miksys, S., and Tyndale, R. F. 2009. Differential induction of ethanol-metabolizing CYP2E1 and nicotinemetabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake. Eur. J. Pharmacol. 609:88-95.